Pacylex Pharmaceuticals
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$14.96M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pacylex Pharmaceuticals is a pharmaceutical company that develops N-myristoyltransferase inhibitors as targeted therapies for hematologic and solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pacylex Pharmaceuticals Comparables
Compare Pacylex Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SignalChem Lifesciences Corporation | 77% | |
| Novartis | 73% | |
| BioTheryX | 72% | |
Pacylex Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Grant | Oct 12, 2022 | ||||
| Series A | Jun 2, 2021 | ||||
| Grant | Jun 1, 2020 | ||||
| Convertible Debt | Mar 4, 2020 |
Key People
Founding team and executive leadership
Pacylex Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Alberta Innovates | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 598% MoM.
- May 1, 2025
Monthly visitors increased 229% MoM.
Pacylex Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pacylex Pharmaceuticals's valuation, stock price, and market status.